Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months
D. Ponticelli, Ippazio Cosimo Antonazzo, Grazia Caci, et al.
Journal of Travel Medicine (2021) Vol. 28, Iss. 8
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 116
The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies
Pietro Ferrara, Vincenza Gianfredi, Venera Tomaselli, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 303-303
Open Access | Times Cited: 73
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
Pietro Ferrara, D. Ponticelli, Fernando Agüero, et al.
Public Health (2022) Vol. 203, pp. 97-99
Open Access | Times Cited: 49
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
Katharina Willuweit, Alexandra Frey, Moritz Passenberg, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 377-377
Open Access | Times Cited: 39
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals
Duaa W. Al‐Sadeq, Farah M. Shurrab, Ahmed Ismail, et al.
Journal of Travel Medicine (2021) Vol. 28, Iss. 8
Open Access | Times Cited: 23
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
Christoph Thurm, Annegret Reinhold, Katrin Borucki, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 333-333
Open Access | Times Cited: 18
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study
Pietro Ferrara, D. Ponticelli, Lorenzo Losa, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 9
Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies
Matthaios Speletas, Ioanna Voulgaridi, Styliani Sarrou, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 316-316
Open Access | Times Cited: 13
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
Venera Tomaselli, Pietro Ferrara, Giulio Giacomo Cantone, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 6, pp. 1617-1630
Open Access | Times Cited: 13
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 13
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
Pietro Ferrara, D. Ponticelli, Roberto Magliuolo, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1353-1353
Open Access | Times Cited: 11
Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
Natalia Syrimi, Flora Sourri, Maria-Christina Giannakopoulou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3172-3172
Open Access | Times Cited: 6
Long Lasting Cellular Immune Response Induced by mRNA Vaccination: Implication for Prevention Strategies
Laura Vitiello, Lucia Gatta, Sara Ilari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
Pietro Ferrara, Ippazio Cosimo Antonazzo, Riccardo Polosa
Internal and Emergency Medicine (2022) Vol. 17, Iss. 1, pp. 313-314
Open Access | Times Cited: 6
COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
Janet Sultana, Grazia Caci, Giulia Hyeraci, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 2, pp. 325-327
Open Access | Times Cited: 4
The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness
Pietro Ferrara, LG Mantovani
Farmeconomia Health economics and therapeutic pathways (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers
Alejandro Vallejo, Pilar Vizcarra, Adrián Martín-Hondarza, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 4
Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine
Hidenori Matsunaga, Hidefumi Takeuchi, Yuichiro Oba, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 177-177
Open Access | Times Cited: 3
Longitudinal Immunological Analysis of Portuguese Healthcare Workers Across the COVID-19 Pandemic Reveals Differences in the Humoral Immune Response to Vaccines
Libe Vilela, Anabela G. Silva, A. Santa Cruz, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1358-1358
Open Access
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
Farah M. Shurrab, Duaa W. Al‐Sadeq, Haissam Abou-Saleh, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 191-191
Open Access | Times Cited: 2
Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States
Wataru Ando, Takeshi Horii, Mitsuki Jimbo, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 2
Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination
Jolanta Kiewisz, Damian Drzyzga, Karolina Rozanska, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 640-640
Open Access
Page 1 - Next Page

Scroll to top